Candidiasis, Chronic Mucocutaneous
"Candidiasis, Chronic Mucocutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A clinical syndrome characterized by development, usually in infancy or childhood, of a chronic, often widespread candidiasis of skin, nails, and mucous membranes. It may be secondary to one of the immunodeficiency syndromes, inherited as an autosomal recessive trait, or associated with defects in cell-mediated immunity, endocrine disorders, dental stomatitis, or malignancy.
| Descriptor ID |
D002178
|
| MeSH Number(s) |
C01.539.800.200.100 C01.703.160.165 C01.703.295.165 C17.800.838.208.165
|
| Concept/Terms |
Candidiasis, Chronic Mucocutaneous- Candidiasis, Chronic Mucocutaneous
- Candidiases, Chronic Mucocutaneous
- Chronic Mucocutaneous Candidiases
- Chronic Mucocutaneous Candidiasis
- Mucocutaneous Candidiases, Chronic
- Mucocutaneous Candidiasis, Chronic
|
Below are MeSH descriptors whose meaning is more general than "Candidiasis, Chronic Mucocutaneous".
Below are MeSH descriptors whose meaning is more specific than "Candidiasis, Chronic Mucocutaneous".
This graph shows the total number of publications written about "Candidiasis, Chronic Mucocutaneous" by people in this website by year, and whether "Candidiasis, Chronic Mucocutaneous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2017 | 4 | 1 | 5 |
| 2018 | 5 | 0 | 5 |
| 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Candidiasis, Chronic Mucocutaneous" by people in Profiles.
-
Interferon signature in patients with STAT1 gain-of-function mutation is epigenetically determined. Eur J Immunol. 2019 05; 49(5):790-800.
-
STAT1 gain-of-function compromises skin host defense in the context of IFN-? signaling. J Allergy Clin Immunol. 2019 04; 143(4):1626-1629.e5.
-
Bronchiectasis and Recurrent Respiratory Infections with a De Novo STAT1 Gain-of-Function Variant: First Case in Korea. Yonsei Med J. 2018 Oct; 59(8):1004-1007.
-
Inherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and Adults. J Clin Immunol. 2018 08; 38(6):656-693.
-
Chronic mucocutaneous candidiasis-more than just skin deep. Hong Kong Med J. 2018 08; 24(4):423-425.
-
A Therapeutic Vaccine for Recurrent Vulvovaginal Candidiasis. Clin Infect Dis. 2018 06 01; 66(12):1937-1939.
-
Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism? J Dermatolog Treat. 2018 Aug; 29(5):475-480.
-
STAT1 Gain-of-Function and Dominant Negative STAT3 Mutations Impair IL-17 and IL-22 Immunity Associated with CMC. J Invest Dermatol. 2018 03; 138(3):711-714.
-
Novel signal transducer and activator of transcription 1 mutation disrupts small ubiquitin-related modifier conjugation causing gain of function. J Allergy Clin Immunol. 2018 05; 141(5):1844-1853.e2.
-
A gain-of-function mutation of STAT1: A novel genetic factor contributing to chronic mucocutaneous candidiasis. Acta Microbiol Immunol Hung. 2017 Jun 01; 64(2):191-201.